RE: SP the enigma13 Jun 2023 20:23
Its still early days, the obvious major risks of FDA approval is now out the way , but for many I think evidence of revenue in UK, is crucial, and data has not yet been published, so we can all speculate what an outright blockbuster it is, but in the cold light of day, when the right time comes, I hope FUM take their time, and publish excellent revenues in UK , admittedly this data will over a short time span, with limited outlets (to what is hoped for in future in UK) but it will be the first real evidence to base some calculation of future growth.
The first data on revenues could be enough to light the fuse long before product selling in USA or other, if excellent, everyone will extrapolate across Europe, USA etc for future revenues BUT we do not have this information presently..so still an unknown quantity.
investing now could well be the best time IMO, but will still depend on the data released as its a two edged sword is data, and if, for whatever reason does not impress then may have the opposite effect....but even if data not impressive enough , this can still be rectified over time with experienced BODs IMO.
I think its a done deal in the sense that if data good, share price will reflect future potential even if not selling products in most countries. If data disappointing / bad, the share price will reflect this, and the company will be taken over by some entity who has the knowhow to squeeze every bit of juice from this product. Just my thoughts and could be wrong.
GL ALL